THC Therapeutics, Inc. THCT

THCT Company Overview

THC Therapeutics, Inc. (OTC: THCT) is a publicly traded company that has historically focused on the development and commercialization of products and technologies associated with the cannabis and hemp industries. Public disclosures and OTC market filings indicate that the company pursued opportunities tied to cannabinoid-based consumer products, hydroponic cultivation systems, and related wellness markets. The company has operated primarily within the emerging legal cannabis sector in the United States, a market characterized by evolving state-level regulatory frameworks and limited federal legalization.

The company’s historical business model included efforts to develop intellectual property and cultivation-related technologies intended for licensed cannabis operators and wellness-oriented consumers. Public information suggests that THC Therapeutics evolved through a series of strategic pivots common among microcap cannabis-sector issuers during the late 2010s. Available disclosures indicate periods of limited operational activity and changes in strategic direction over time. Data regarding sustained commercial scale, material recurring revenue, or long-term operational execution remains limited in publicly available filings.